Vanguard Group Inc Akouos, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $132,480 - $262,922	50,954 Added 5.93%	910,851 $6.16 Million
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $138,721 - $293,233	-56,391 Reduced 6.15%	859,897 $4.03 Million
Q1 2022 May 13, 2022	SELL	$4.16 - $9.08 $449,300 - $980,685	-108,005 Reduced 10.54%	916,288 $4.35 Million
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $469,166 - $697,924	-61,329 Reduced 5.65%	1,024,293 $8.71 Million
Q3 2021 Nov 12, 2021	BUY	$9.93 - $13.59 $1.23 Million - $1.68 Million	123,695 Added 12.86%	1,085,622 $12.6 Million
Q2 2021 Aug 13, 2021	BUY	$11.87 - $15.96 $11.4 Million - $15.4 Million	961,927 New	961,927 $12.1 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.